GGrantIndex
← Leaderboards

Jean-Marc Schwarz

Touro University Of California

$10,408,409
Attributed
$16,623,154
Total exposure
7
Grants
5
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $2.3M · FY200725
$2.5M$1.9M$1.3M$625K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$16,623,154 · 7

By mechanism

R01$16,623,154 · 7

Top collaborators

Most similar at Touro University Of California

Same institution · by research overlap

Others in their field

Top investigators on “Consumption

Research focus

ConsumptionMetabolicIntakeProductionFructoseLipid BiosynthesisLipidsDietCarbohydratesLiverFatty Acid Glycerol EstersHepaticGlucoseKineticsSugarFastingFeedingStable IsotopeObesityVisceralInsulin SensitivityLeadMetabolismAdult

Grant awards (33)

Fructose Metabolism Effects on the Liver: Unraveling the Role of Defective Intestinal GNG in Individuals with Obesity$730,498
R01 · FY2025 · DK · contact PI
Fructose: Substrate, Stimulus, or Both?$714,999
R01 · FY2023 · DK · contact PI
Fructose: Substrate, Stimulus, or Both?$714,999
R01 · FY2022 · DK · contact PI
Fructose: Substrate, Stimulus, or Both?$714,999
R01 · FY2020 · DK · contact PI
Fructose: Substrate, Stimulus, or Both?$714,999
R01 · FY2019 · DK · contact PI
Adverse metabolic effects of dietary sugar: Ad libitum vs energy-balanced diets$75,091
R01 · FY2019 · HL
Adverse metabolic effects of dietary sugar _ Ad libitum vs energy-balanced diets$853,462
R01 · FY2018 · HL
Adverse metabolic effects of dietary sugar _ Ad libitum vs energy-balanced diets$874,451
R01 · FY2017 · HL
Lipogenesis, lipoprotein flux & CVD risk: role of meal composition & frequency$616,825
R01 · FY2017 · HL · contact PI
Adverse metabolic effects of dietary sugar _ Ad libitum vs energy-balanced diets$832,999
R01 · FY2016 · HL
Lipogenesis, lipoprotein flux & CVD risk: role of meal composition & frequency$613,174
R01 · FY2016 · HL · contact PI
Adverse metabolic effects of dietary sugar: Ad libitum vs energy-balanced diets$30,536
R01 · FY2016 · HL
Adverse metabolic effects of dietary sugar _ Ad libitum vs energy-balanced diets$735,127
R01 · FY2015 · HL
Lipogenesis, lipoprotein flux & CVD risk: role of meal composition & frequency$607,272
R01 · FY2015 · HL · contact PI
Adverse Metabolic Effects of Dietary Sugar _ Ad Libitum vs Energy-Balanced Diets$65,765
R01 · FY2015 · HL
Adverse metabolic effects of dietary sugar _ Ad libitum vs energy-balanced diets$743,385
R01 · FY2014 · HL
Lipogenesis, lipoprotein flux & CVD risk: role of meal composition & frequency$604,426
R01 · FY2014 · HL · contact PI
Metabolic impact of fructose restriction in obese children$506,343
R01 · FY2014 · DK · contact PI
Fatty acid sources of fructose and HFCS-induced postprandial hypertriglyceridemia$355,618
R01 · FY2014 · HL
Metabolic impact of fructose restriction in obese children$100,000
R01 · FY2014 · DK · contact PI
Lipogenesis, lipoprotein flux & CVD risk: role of meal composition & frequency$623,638
R01 · FY2013 · HL · contact PI
Metabolic impact of fructose restriction in obese children$501,437
R01 · FY2013 · DK · contact PI
Fatty acid sources of fructose and HFCS-induced postprandial hypertriglyceridemia$360,198
R01 · FY2013 · HL
Metabolic impact of fructose restriction in obese children$535,277
R01 · FY2012 · DK · contact PI
Fatty acid sources of fructose and HFCS-induced postprandial hypertriglyceridemia$378,552
R01 · FY2012 · HL
Metabolic impact of fructose restriction in obese children$563,771
R01 · FY2011 · DK · contact PI
Fatty acid sources of fructose and HFCS-induced postprandial hypertriglyceridemia$379,866
R01 · FY2011 · HL
Metabolic impact of fructose restriction in obese children$741,779
R01 · FY2010 · DK · contact PI
De novo lipogenesis in the pathogenesis of non-alcoholic fatty liver disease$299,360
R01 · FY2010 · DK · contact PI
De novo lipogenesis in the pathogenesis of non-alcoholic fatty liver disease$350,924
R01 · FY2009 · DK · contact PI
De novo lipogenesis in the pathogenesis of non-alcoholic fatty liver disease$1,530
R01 · FY2009 · DK · contact PI
De novo lipogenesis in the pathogenesis of non-alcoholic fatty liver disease$347,102
R01 · FY2008 · DK · contact PI
De novo lipogenesis in the pathogenesis of non-alcoholic fatty liver disease$334,752
R01 · FY2007 · DK · contact PI